M. Karamouzis – Current treatment options for advanced, inoperable, metastatic GIST

J. Duran Moreno – Mechanisms of Resistance of recurrent and metastatic GIST

V. Ramfidis – Lung sarcomas: a study of the Hellenic Group

A. Kyriazoglou – A case series of BCOR sarcomas from the Hellenic Group

E. Skarpidi – NTRK rearranged mesenchymal tumors: pathologic approach

C. Stathopoulos – The dark matter of the genomes: the non coding RNAs in sarcomas

C. Valverde – NTRK in sarcomas. Diagnostic strategy

E. Skarpidi – Changes in WHO classification of STS

R. Jones – Advanced soft tissue sarcomas: Beyond olaratumab

G. Agrogiannis – Extra – uterine leiomyosarcomas, pathology risk

S. Kokkali – Current treatment options in LMS and future perspectives

P. Megas – Osteosarcoma surgical approach

V. Kontogeorgakos – Pelvic sarcomas

J. Y. Blay – WHO classification changes and clinical utility

D.J. Papachristou – Mesenchymal stem cells: key drivers to sarcoma development, diagnosis and …